These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 26941171
1. Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice. Martínez-Águila A, Fonseca B, Pérez de Lara MJ, Pintor J. J Pharmacol Exp Ther; 2016 May; 357(2):293-9. PubMed ID: 26941171 [Abstract] [Full Text] [Related]
3. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma. Crooke A, Huete-Toral F, Martínez-Águila A, Martín-Gil A, Pintor J. J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996 [Abstract] [Full Text] [Related]
9. The melatonin analog 5-MCA-NAT increases endogenous dopamine levels by binding NRH:quinone reductase enzyme in the developing chick retina. Sampaio Lde F, Mesquita FP, de Sousa PR, Silva JL, Alves CN. Int J Dev Neurosci; 2014 Nov; 38():119-26. PubMed ID: 25218627 [Abstract] [Full Text] [Related]
10. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. Alarma-Estrany P, Crooke A, Peral A, Pintor J. Auton Neurosci; 2007 Dec 30; 137(1-2):63-6. PubMed ID: 17804303 [Abstract] [Full Text] [Related]
11. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. Huete-Toral F, Crooke A, Martínez-Águila A, Pintor J. J Pharmacol Exp Ther; 2015 Jan 30; 352(1):119-28. PubMed ID: 25344385 [Abstract] [Full Text] [Related]
16. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies. Juszczak M, Roszczyk M, Kowalczyk E, Stempniak B. J Physiol Pharmacol; 2014 Dec 30; 65(6):777-84. PubMed ID: 25554981 [Abstract] [Full Text] [Related]
17. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. Alarma-Estrany P, Crooke A, Pintor J. J Pineal Res; 2009 Sep 30; 47(2):201-209. PubMed ID: 19627460 [Abstract] [Full Text] [Related]
18. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Molinari EJ, North PC, Dubocovich ML. Eur J Pharmacol; 1996 Apr 22; 301(1-3):159-68. PubMed ID: 8773460 [Abstract] [Full Text] [Related]
19. Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma. Fonseca B, Martínez-Águila A, de Lara MJP, Pintor J. Purinergic Signal; 2017 Jun 22; 13(2):171-177. PubMed ID: 27848070 [Abstract] [Full Text] [Related]
20. Effect of Antiglaucoma Medicine on Intraocular Pressure in DBA/2J Mice. Sawada K, Hiraoka M, Ohguro H. Ophthalmic Res; 2016 Jun 22; 55(4):205-11. PubMed ID: 26942413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]